Pharmacogenomics for Adverse Drug Reactions

The Texas Interprofessional Pharmacogenomics (IPGx)

Recruiting Observational Study
Adverse Drug Reaction
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
45 and older
Sex
Any
Study type
Observational
Participants needed
50 (estimated)
Sponsor
Texas A&M University · Other
Who this trial is looking for

This trial is looking for patients who take multiple medications and may be at risk for bad reactions to those drugs. Participants will provide samples and share health information to help doctors improve medication safety.

Are You a Good Fit for This Trial?
Must not be taking Imidazole antifungal medication
Rules you out Active liver diseaseHepatitis BHepatitis CAlzheimer's disease

You may be able to join if

  • I take 5 or more medications
  • I can give consent to participate
  • I can provide urine and saliva samples
  • I am at least 45 years old

You may not be able to join if

  • I have been treated for cancer in the last 5 years
  • I am currently in hospice care
  • I have had Hepatitis B or C
  • I have active liver disease or severe liver issues
  • I take imidazole antifungal medications
  • I do not want to participate or share my medical status
  • I have been diagnosed with Alzheimer's disease
  • I am pregnant

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The investigator's primary aim is to evaluate polypharmacy-associated adverse drug reactions (ADR) in a pilot study of at-risk patients using state-of-the-art pharmacogenomic technology and to use this information to make recommendations for optimization of pharmacotherapy regimens. The data from the pilot cohort will be used to optimize and integrate a customized electronic decision support (clin…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * People taking 5 or more medications, including over the counter drugs, supplements, natural products, cannabis produces, or other recreational drugs * Ability to give and comprehend the consent process. * Consent to donate urine samples, genetic data through buccal swabs, unde…
Contacts

Kenneth S Ramos, MD

7136777740

kramos@tamu.edu

CONTACT